248 related articles for article (PubMed ID: 32651598)
1. Catalytically-active inclusion bodies for biotechnology-general concepts, optimization, and application.
Jäger VD; Lamm R; Küsters K; Ölçücü G; Oldiges M; Jaeger KE; Büchs J; Krauss U
Appl Microbiol Biotechnol; 2020 Sep; 104(17):7313-7329. PubMed ID: 32651598
[TBL] [Abstract][Full Text] [Related]
2. Catalytically-active inclusion bodies-Carrier-free protein immobilizates for application in biotechnology and biomedicine.
Krauss U; Jäger VD; Diener M; Pohl M; Jaeger KE
J Biotechnol; 2017 Sep; 258():136-147. PubMed ID: 28465211
[TBL] [Abstract][Full Text] [Related]
3. Tailoring the properties of (catalytically)-active inclusion bodies.
Jäger VD; Kloss R; Grünberger A; Seide S; Hahn D; Karmainski T; Piqueray M; Embruch J; Longerich S; Mackfeld U; Jaeger KE; Wiechert W; Pohl M; Krauss U
Microb Cell Fact; 2019 Feb; 18(1):33. PubMed ID: 30732596
[TBL] [Abstract][Full Text] [Related]
4. Design, Production, and Characterization of Catalytically Active Inclusion Bodies.
Ölçücü G; Jaeger KE; Krauss U
Methods Mol Biol; 2023; 2617():49-74. PubMed ID: 36656516
[TBL] [Abstract][Full Text] [Related]
5. Catalytically Active Inclusion Bodies─Benchmarking and Application in Flow Chemistry.
Ölçücü G; Baumer B; Küsters K; Möllenhoff K; Oldiges M; Pietruszka J; Jaeger KE; Krauss U
ACS Synth Biol; 2022 May; 11(5):1881-1896. PubMed ID: 35500299
[TBL] [Abstract][Full Text] [Related]
6. Construction and comprehensive characterization of an EcLDCc-CatIB set-varying linkers and aggregation inducing tags.
Küsters K; Pohl M; Krauss U; Ölçücü G; Albert S; Jaeger KE; Wiechert W; Oldiges M
Microb Cell Fact; 2021 Feb; 20(1):49. PubMed ID: 33596923
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of BsGDH-CatIB variants and application as robust and highly active redox cofactor regeneration module for biocatalysis.
Küsters K; Saborowski R; Wagner C; Hamel R; Spöring JD; Wiechert W; Oldiges M
Microb Cell Fact; 2022 Jun; 21(1):108. PubMed ID: 35655182
[TBL] [Abstract][Full Text] [Related]
8. "High-throughput screening of catalytically active inclusion bodies using laboratory automation and Bayesian optimization".
Helleckes LM; Küsters K; Wagner C; Hamel R; Saborowski R; Marienhagen J; Wiechert W; Oldiges M
Microb Cell Fact; 2024 Feb; 23(1):67. PubMed ID: 38402403
[TBL] [Abstract][Full Text] [Related]
9. Automated Characterization of Catalytically Active Inclusion Body Production in Biotechnological Screening Systems.
Ruzaeva K; Kusters K; Wiechert W; Berkels B; Oldiges M; Noh K
Annu Int Conf IEEE Eng Med Biol Soc; 2022 Jul; 2022():3874-3877. PubMed ID: 36086505
[TBL] [Abstract][Full Text] [Related]
10. Bacterial inclusion bodies: making gold from waste.
García-Fruitós E; Vázquez E; Díez-Gil C; Corchero JL; Seras-Franzoso J; Ratera I; Veciana J; Villaverde A
Trends Biotechnol; 2012 Feb; 30(2):65-70. PubMed ID: 22037492
[TBL] [Abstract][Full Text] [Related]
11. A Synthetic Reaction Cascade Implemented by Colocalization of Two Proteins within Catalytically Active Inclusion Bodies.
Jäger VD; Lamm R; Kloß R; Kaganovitch E; Grünberger A; Pohl M; Büchs J; Jaeger KE; Krauss U
ACS Synth Biol; 2018 Sep; 7(9):2282-2295. PubMed ID: 30053372
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of inclusion bodies for bio-based products: curse or blessing?
Slouka C; Kopp J; Spadiut O; Herwig C
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
[TBL] [Abstract][Full Text] [Related]
13. Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.
Bajaj P; Tripathy RK; Aggarwal G; Pande AH
Protein Expr Purif; 2015 Nov; 115():95-101. PubMed ID: 26003526
[TBL] [Abstract][Full Text] [Related]
14. Catalytically active inclusion bodies as a potential tool for biotechnology.
Bello MN; Sabri S; Mohd Yahaya N; Mohd Shariff F; Mohamad Ali MS
Biotechnol Appl Biochem; 2024 Jun; ():. PubMed ID: 38863240
[TBL] [Abstract][Full Text] [Related]
15. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
[TBL] [Abstract][Full Text] [Related]
16. Exploring the use of leucine zippers for the generation of a new class of inclusion bodies for pharma and biotechnological applications.
Roca-Pinilla R; Fortuna S; Natalello A; Sánchez-Chardi A; Ami D; Arís A; Garcia-Fruitós E
Microb Cell Fact; 2020 Sep; 19(1):175. PubMed ID: 32887587
[TBL] [Abstract][Full Text] [Related]
17. Thermostable adenosine 5'-monophosphate phosphorylase from Thermococcus kodakarensis forms catalytically active inclusion bodies.
Kamel S; Walczak MC; Kaspar F; Westarp S; Neubauer P; Kurreck A
Sci Rep; 2021 Aug; 11(1):16880. PubMed ID: 34413335
[TBL] [Abstract][Full Text] [Related]
18. New properties of inclusion bodies with implications for biotechnology.
Peternel S; Jevsevar S; Bele M; Gaberc-Porekar V; Menart V
Biotechnol Appl Biochem; 2008 Apr; 49(Pt 4):239-46. PubMed ID: 17708747
[TBL] [Abstract][Full Text] [Related]
19. Catalytically active inclusion bodies of L-lysine decarboxylase from E. coli for 1,5-diaminopentane production.
Kloss R; Limberg MH; Mackfeld U; Hahn D; Grünberger A; Jäger VD; Krauss U; Oldiges M; Pohl M
Sci Rep; 2018 Apr; 8(1):5856. PubMed ID: 29643457
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Inclusion Body Formation and Purification in Multi-well Plates.
Kamel S; Schollmeyer J; Kurreck A; Neubauer P
Methods Mol Biol; 2023; 2617():121-138. PubMed ID: 36656520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
